Stonepine Capital Management, LLC 13D and 13G filings for Aprea Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-13 12:15 pm Sale | 2024-12-31 | 13G | Aprea Therapeutics, Inc. APRE | Stonepine Capital Management, LLC | 286,395 5.100% | -79,041 (-21.63%) | Filing |
| 2024-10-10 4:07 pm Purchase | 2024-10-07 | 13G | Aprea Therapeutics, Inc. APRE | Stonepine Capital Management, LLC | 365,436 6.600% | 365,436 (New Position) | Filing |